Biofeedback plus standard therapy vs usual care: Clinical remission or improvement
It is very uncertain whether biofeedback plus standard therapy changes clinical response (adequate improvement or remission) compared with standard therapy (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Biofeedback plus standard therapy vs standard therapy Clinical response (adequate improvement or remission) · people with irritable bowel syndrome It is very uncertain whether biofeedback plus standard therapy changes clinical response (adequate improvement or remission) compared with standard therapy (very low certainty). Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane Headline outcomes only | RR 4.2 [1.4, 12.58] | 1 study · 20 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.